TLR7 promotes chronic airway disease in RSV-infected mice

dc.contributor.authorMiles, M.A.
dc.contributor.authorLiong, S.
dc.contributor.authorLiong, F.
dc.contributor.authorCoward Smith, M.
dc.contributor.authorTrollope, G.S.
dc.contributor.authorOseghale, O.
dc.contributor.authorErlich, J.R.
dc.contributor.authorBrooks, R.D.
dc.contributor.authorLogan, J.M.
dc.contributor.authorHickey, S.
dc.contributor.authorWang, H.
dc.contributor.authorBozinovski, S.
dc.contributor.authorO'Leary, J.J.
dc.contributor.authorBrooks, D.A.
dc.contributor.authorSelemidis, S.
dc.date.issued2023
dc.descriptionData source: Supplementary material, https://doi.org/10.3389/fimmu.2023.1240552
dc.description.abstractRespiratory syncytial virus (RSV) commonly infects the upper respiratory tract (URT) of humans, manifesting with mild cold or flu-like symptoms. However, in infants and the elderly, severe disease of the lower respiratory tract (LRT) often occurs and can develop into chronic airway disease. A better understanding of how an acute RSV infection transitions to a LRT chronic inflammatory disease is critically important to improve patient care and long-term health outcomes. To model acute and chronic phases of the disease, we infected wild-type C57BL/6 and toll-like receptor 7 knockout (TLR7 KO) mice with RSV and temporally assessed nasal, airway and lung inflammation for up to 42 days post-infection. We show that TLR7 reduced viral titers in the URT during acute infection but promoted pronounced pathogenic and chronic airway inflammation and hyperreactivity in the LRT. This study defines a hitherto unappreciated molecular mechanism of lower respiratory pathogenesis to RSV, highlighting the potential of TLR7 modulation to constrain RSV pathology to the URT.
dc.identifier.citationFrontiers in Immunology, 2023; 14:1-21
dc.identifier.doi10.3389/fimmu.2023.1240552
dc.identifier.issn1664-3224
dc.identifier.issn1664-3224
dc.identifier.orcidHickey, S. [0000-0002-3063-531X]
dc.identifier.orcidBrooks, D.A. [0000-0001-9098-3626]
dc.identifier.urihttps://hdl.handle.net/11541.2/36160
dc.language.isoen
dc.publisherFrontiers Research Foundation
dc.relation.fundingNHMRC 1122506
dc.relation.fundingNHMRC 1128276
dc.rightsCopyright 2023 Miles, Liong, Liong, Coward-Smith, Trollope, Oseghale, Erlich, Brooks, Logan, Hickey, Wang, Bozinovski, O’Leary, Brooks and Selemidis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. (https://creativecommons.org/licenses/by/4.0/)
dc.source.urihttps://doi.org/10.3389/fimmu.2023.1240552
dc.subjecttoll-like receptor 7
dc.subjectrespiratory syncytial virus
dc.subjectinflammation
dc.subjectairway hyperreactivity
dc.subjectviral infection
dc.subjectBronchi
dc.subjectAnimals
dc.subjectMice, Inbred C57BL
dc.subjectMice, Knockout
dc.subjectMice
dc.subjectRespiratory Syncytial Virus Infections
dc.subjectAsthma
dc.subjectPulmonary Disease, Chronic Obstructive
dc.titleTLR7 promotes chronic airway disease in RSV-infected mice
dc.typeJournal article
pubs.publication-statusPublished
ror.fileinfo12276477360001831 13276486080001831 Open Access Published Version
ror.mmsid9916800115101831

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
9916800115101831_12276477360001831_TLR7 promotes chronic airway disease in RSV-infected mice.pdf
Size:
21.72 MB
Format:
Adobe Portable Document Format
Description:
Published version

Collections